| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.13 | 0.5 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.5 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |